Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/642"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1397"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	"none_assigned"
?:Evidence_type	?:Non_Tracable_Statement
?:Evidence_value	"0.0006448"
?:content	"The FDA, in it most recent guidance document, recommends this as a chemical inhibitor of CYP2C8 for in vitro experiments at a K_i of 1.1micM. See Table 2, p. 28 1.1micM/L X 1M/10^6micM X 586.183g/M = 0.0006448g/L"
dc:creator	"boycer"
dc:date	"06/30/2009 13:49:04"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ montelukast_inhibition_constant_cyp2c8, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1397 }

Context graph